1h Free Analyst Time
The dermatological drugs market is forecasted to grow by USD 11.99 billion during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the dermatological drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by need for safe and stable drugs that require minimal monitoring, emergence of improved diagnostic modalities, and need for affordable dermatological therapies.
The dermatological drugs market is segmented as below:
By Product
- Biologics
- Small molecules
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the dermatological drugs market covers the following areas:
- Dermatological drugs market sizing
- Dermatological drugs market forecast
- Dermatological drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global dermatological drugs market: AbbVie, Amgen Inc., Bausch Health Companies Inc., Botanix Pharmaceutical, Bristol Myers Squibb Co., Cipla Inc., DR Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Galderma SA, GlaxoSmithKline PLC, Johnson and Johnson Services Inc., LEO Pharma AS, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sol Gel Technologies Ltd., Sun Pharmaceutical Industries Ltd., UCB SA, and Vibcare Pharma Pvt. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in prices of dermatological drugs."
According to the report, one of the major drivers for this market is the need for safe and stable drugs that require minimal monitoring.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie
- Amgen Inc.
- Bausch Health Companies Inc.
- Botanix Pharmaceutical
- Bristol Myers Squibb Co.
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- Galderma SA
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- LEO Pharma AS
- Lupin Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Sol Gel Technologies Ltd.
- Sun Pharmaceutical Industries Ltd.
- UCB SA
- Vibcare Pharma Pvt. Ltd.
